Showing 21-30 of 348 results for "".
- How to Handle “High-Maintenance” Patientshttps://practicalneurology.com/columns/practice-management/how-to-handle-high-maintenance-patients/31354/Managing patients with chronic headaches and other pain conditions presents significant challenges, particularly when psychiatric comorbidities or substance abuse are involved. In her article for Practical Neurology, Dawn C. Buse, PhD, outlines strategies for healthcare professionals to effectively
- Taking a Closer Look at AED Drug Interactionshttps://practicalneurology.com/columns/practice-management/taking-a-closer-look-at-aed-drug-interactions/31394/Understanding Drug Interactions in Antiepileptic TherapyManaging epilepsy effectively requires a comprehensive understanding of antiepileptic drug (AED) interactions, which can significantly impact patient outcomes. In their September 2005 article in *Practical Neurology*, Angela K. Birnbaum, PhD, a
- Examining the Health of Medical Malpractice Coveragehttps://practicalneurology.com/columns/practice-management/examining-the-health-of-medical-malpractice-coverage/31035/Medical malpractice litigation remains a significant concern for neurologists, ranking high among professional anxieties alongside breaches of medical ethics. According to Marc Nuwer, MD, PhD of UCLA, a substantial number of physicians face lawsuits during their careers, often driven not by actual m
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31085/Managing Personality Disorders in Dementia Patients: Expert InsightsIn the December 2007 issue of *Practical Neurology*, a panel of experts discusses the complexities of treating personality disorders in dementia patients, focusing on pharmacological strategies and the implications of recent studies
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31140/Impact of SSRIs on Bone Health in Elderly Patients: Clinical InsightsRecent studies have raised concerns about the use of selective serotonin reuptake inhibitors (SSRIs) and their potential negative effects on bone health in older adults. These findings pose important considerations for neurologists
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31223/CPT 2007 Updates Impact Neurology PracticesThe 2007 update to the Current Procedural Terminology (CPT) manual introduces several significant changes pertinent to neurology practices, as outlined by Mary H. McDermott in Practical Neurology. While the overall modifications affecting neurology are limi
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
Beyond the Symptoms: The True Impact of gMG on Patients' Lives
https://practicalneurology.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
https://practicalneurology.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies
https://practicalneurology.com/programs/cme/precision-medicine-in-myasthenia-gravis-crafting-personalized-treatment-strategies/32244/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.